These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 2196078

  • 1. Side-effects of psoralen photochemotherapy (PUVA).
    Wolff K.
    Br J Dermatol; 1990 Jun; 122 Suppl 36():117-25. PubMed ID: 2196078
    [Abstract] [Full Text] [Related]

  • 2. Minimising the risks of PUVA treatment.
    van Praag MC, Tseng LN, Mommaas AM, Boom BW, Vermeer BJ.
    Drug Saf; 1993 May; 8(5):340-9. PubMed ID: 8504016
    [Abstract] [Full Text] [Related]

  • 3. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA.
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [Abstract] [Full Text] [Related]

  • 4. Consensus workshop on the toxic effects of long-term PUVA therapy.
    Morison WL, Baughman RD, Day RM, Forbes PD, Hoenigsmann H, Krueger GG, Lebwohl M, Lew R, Naldi L, Parrish JA, Piepkorn M, Stern RS, Weinstein GD, Whitmore SE.
    Arch Dermatol; 1998 May; 134(5):595-8. PubMed ID: 9606329
    [Abstract] [Full Text] [Related]

  • 5. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS.
    Blood Cells; 1992 May; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [Abstract] [Full Text] [Related]

  • 6. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. An 8-year follow-up study.
    Tanew A, Hönigsmann H, Ortel B, Zussner C, Wolff K.
    J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):960-5. PubMed ID: 3782536
    [Abstract] [Full Text] [Related]

  • 7. Long-term risks of psoralen and UV-A therapy for psoriasis.
    Farber EM, Abel EA, Cox AJ.
    Arch Dermatol; 1983 May; 119(5):426-31. PubMed ID: 6342539
    [Abstract] [Full Text] [Related]

  • 8. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS, PUVA Follow-Up Study.
    J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
    [Abstract] [Full Text] [Related]

  • 9. [Photochemotherapy (PUVA): pro and con].
    Wolff K.
    Hautarzt; 1985 Jan; 36(1):25-33. PubMed ID: 3918959
    [Abstract] [Full Text] [Related]

  • 10. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
    Stern RS, Laird N.
    Cancer; 1994 Jun 01; 73(11):2759-64. PubMed ID: 8194017
    [Abstract] [Full Text] [Related]

  • 11. Psoralen photochemotherapy.
    Gupta AK, Anderson TF.
    J Am Acad Dermatol; 1987 Nov 01; 17(5 Pt 1):703-34. PubMed ID: 3316316
    [Abstract] [Full Text] [Related]

  • 12. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS, Liebman EJ, Väkevä L.
    J Natl Cancer Inst; 1998 Sep 02; 90(17):1278-84. PubMed ID: 9731734
    [Abstract] [Full Text] [Related]

  • 13. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
    Gasparro FP.
    Am J Clin Dermatol; 2000 Sep 02; 1(6):337-48. PubMed ID: 11702610
    [Abstract] [Full Text] [Related]

  • 14. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
    Stern RS, Nichols KT, Väkevä LH.
    N Engl J Med; 1997 Apr 10; 336(15):1041-5. PubMed ID: 9091799
    [Abstract] [Full Text] [Related]

  • 15. The benefits and risks of long-term PUVA photochemotherapy.
    Momtaz K, Fitzpatrick TB.
    Dermatol Clin; 1998 Apr 10; 16(2):227-34. PubMed ID: 9589196
    [Abstract] [Full Text] [Related]

  • 16. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
    Henseler T, Christophers E.
    Natl Cancer Inst Monogr; 1984 Dec 10; 66():217-9. PubMed ID: 6531033
    [Abstract] [Full Text] [Related]

  • 17. Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis.
    Henseler T, Christophers E, Hönigsmann H, Wolff K.
    J Am Acad Dermatol; 1987 Jan 10; 16(1 Pt 1):108-16. PubMed ID: 3805379
    [Abstract] [Full Text] [Related]

  • 18. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?
    Lindelöf B.
    Drug Saf; 1999 Apr 10; 20(4):289-97. PubMed ID: 10230579
    [Abstract] [Full Text] [Related]

  • 19. PUVA, UVB, psoriasis, and nonmelanoma skin cancer.
    Studniberg HM, Weller P.
    J Am Acad Dermatol; 1993 Dec 10; 29(6):1013-22. PubMed ID: 8245237
    [Abstract] [Full Text] [Related]

  • 20. Epidermal dystrophy and actinic keratoses in psoriasis patients following oral psoralen photochemotherapy (PUVA). Follow-up study.
    Abel EA, Cox AJ, Farber EM.
    J Am Acad Dermatol; 1982 Sep 10; 7(3):333-40. PubMed ID: 7130492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.